Balance Sheet for Cumberland Pharmaceuticals Inc. (CPIX)

$ 3.24   -0.04 (-1.22%) Volume: 5.52k 1:29 PM EDT Jul 9, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 28,213 27,939 45,413 34,510 38,203
Restrictable Cash - - - - -
Marketable Securities - 8,291 4,672 15,622 14,564
Accounts Receivable 9,781 7,844 8,395 7,330 6,077
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 9,781 7,844 8,395 7,330 6,077
Inventories, Raw Materials - 7,738 3,156 2,811 2,577
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - 11,127 3,332 2,284 1,458
Inventories, Other 9,412 13,646 6,988 5,649 4,506
Inventories, Adjustments & Allowances - - - - -
Inventories 9,412 12,078 6,738 5,372 4,270
Prepaid Expenses 2,757 2,964 3,467 2,711 1,469
Current Deferred Income Taxes - - - - 2,529
Other Current Assets - - - - -
Total Current Assets 50,163 59,116 68,685 65,545 64,583
Land and Improvements - - - - -
Buildings and Improvement 1,357 1,299 1,275 1,256 1,243
Machinery, Furniture and Equipment 2,785 2,597 2,166 1,908 1,790
Construction in Progress - - - - -
Fixed Assets, Other 2,961 - - - -
Fixed Assets, Total 7,103 3,896 3,440 3,164 3,034
Gross Fixed Assets 7,103 3,896 3,440 3,164 3,034
Accumulated Depreciation (3,394) (3,125) (2,911) (2,700) (2,497)
Net Fixed Assets 3,708 771 529 464 536
Intangibles 30,920 33,655 21,445 22,154 21,169
Cost in Excess 882 784 - - -
Non-Current Deferred Income Taxes 22 87 87 3,120 3,740
Other Non-Current Assets 18,854 18,280 2,487 2,121 1,891
Total Non-Current Assets 54,386 53,578 24,547 27,859 27,336
Total Assets 104,549 112,694 93,232 93,405 91,919
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 11,912 12,179 10,305 9,027 2,877
Short Term Debt 920 - - - -
Notes Payable - - - - -
Accrued Expenses 4,204 2,724 1,055 319 -
Accrued Liabilities 4,204 2,724 1,055 319 -
Deferred Revenues - - - - -
Current Deferred Income Taxes 65 82 4,207 620 490
Other Current Liabilities 7,114 12,901 6,335 5,446 9,534
Total Current Liabilities 24,150 27,804 17,695 14,792 12,412
Long Term Debt 18,500 20,000 9,800 4,100 1,700
Deferred Income Tax - - - - -
Other Non-Current Liabilities 8,737 9,319 1,816 1,391 987
Minority Interest (38) (274) (199) (127) (68)
Capital Lease Obligations 2,076 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 29,276 29,045 11,417 5,364 2,619
Total Liabilities 53,426 56,849 29,112 20,156 15,031
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 51,123 55,845 64,120 73,248 76,888
Common Par 49,914 51,099 52,411 - -
Additional Paid in Capital - - - 54,643 57,338
Cumulative Translation Adjustments - - - - -
Retained Earnings 1,208 4,746 11,709 18,605 19,550
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 69,623 75,845 73,920 77,348 78,588
Total Equity 51,123 55,845 64,120 73,248 76,888
Total Liabilities & Shareholder's Equity 104,549 112,694 93,232 93,405 91,919
Cash Flow (3,547) (7,039) (8,050) (1,004) 671
Working Capital 26,013 31,312 50,990 50,753 52,172
Free Cash Flow 2,037 (1,162) (2,047) (1,562) 3,177
Invested Capital 69,623 75,845 73,920 77,348 78,588
Shares Outstanding - Common Class Only 15,264 15,481 15,723 16,074 16,380
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 15,264 15,481 15,723 16,074 16,380
Total Common Shares Outstanding 15,264 15,481 15,723 16,074 16,380
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 15,396 15,614 15,912 16,237 16,716
Diluted Weighted Shares Outstanding 15,396 15,614 15,912 16,237 17,095